Raleigh-based Innovate Biopharma raises $9.7 million in new capital
Under the deal, some 4.1 million shares of common stock will be sold at $4 per share, and up to 2.5 million shares at $2.56 per share.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
